The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Ubigene Biosciences
New York, United States
B
51-100 Employees
-
Key takeaway
Ubigene is dedicated to making genome editing easier, offering advanced gene-editing services and products. Their innovative CRISPR-U™ technology significantly enhances gene-editing efficiency, and they provide a comprehensive automated design system that supports researchers in this field.
Highlighted product
Service
| Ubigene
Edilytics
Cambridge, United States
B
1-10 Employees
2019
Key takeaway
Edilytics offers advanced precision genome editing solutions, highlighting CRISPResso2 as a trusted tool for analyzing gene editing experiments. This platform provides comprehensive data and user-friendly features, making it suitable for both academia and industry.
Highlighted product
Core business
Edilytics | Precision Genome Editing Analysis
Inscripta
Boulder, United States
B
101-250 Employees
2015
Key takeaway
The company highlights its innovative approach to gene editing through methods like CRISPR and Directed Evolution, which enhance biomanufacturing and enable the discovery of beneficial genetic changes. Their digital genome engineering tools promise to transform various fields, including material production, agriculture, and disease treatment.
Highlighted product
Product
Genome Editing - Inscripta®
Our revolutionary digital genome engineering tools transform how we face complex global challenges and yield solutions that benefit all.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Scribe Therapeutics
United States
B
11-50 Employees
2017
Key takeaway
The company is focused on advancing gene editing through innovative delivery technologies that enhance in vivo genetic medicine. Their approach emphasizes precision targeting within the genome, which is essential for developing effective therapies.
Highlighted product
Core business
Scribe
Alliance Regenerative Medicine
Washington, United States
B
11-50 Employees
2009
Key takeaway
The company is focused on advancing gene therapies, which are a key component of regenerative medicine aimed at repairing and regenerating biological functions. Their commitment to innovative access and funding models highlights the transformative potential of these therapies in healthcare.
Highlighted product
Product
Genome Editing - Alliance for Regenerative Medicine
Metagenomi
Emeryville, United States
B
51-100 Employees
2018
Key takeaway
Metagenomi is developing potentially curative therapeutics through its metagenomics-powered gene editing toolbox, which utilizes undiscovered genetic material from natural environments. Their approach aims to create innovative genetic medicines by matching optimal gene editing tools to specific medical indications.
Highlighted product
Core business
Curative Gene Editing Forged From Nature | Metagenomi
Metagenomi is transforming novel gene editing tools, mined from the world’s natural microbial environment, into life-saving genetic medicines.
Life Edit
Morrisville, United States
B
11-50 Employees
2017
Key takeaway
The company is focused on curing genetic diseases through innovative gene editing therapies. Their next-generation platform enables precise targeting of genomic sequences, allowing for the development of advanced treatments for challenging genetic disorders.
Highlighted product
Core business
About
GeneCopoeia
Rockville, United States
B
11-50 Employees
2000
Key takeaway
GeneCopoeia offers CRISPR and TALEN genome editing tools, highlighting their focus on advanced genetic engineering techniques. Their partnership with researchers and biotechnology companies ensures high-quality, fully sequenced ORF clones and related particles, which are essential for effective gene editing.
Highlighted product
Product
CRISPR & TALEN Genome Editing Tools | Genecopoeia
Emendo Biotherapeutics
New York, United States
B
11-50 Employees
2015
Key takeaway
EmendoBio is advancing CRISPR technology to address complex genetic diseases, enhancing traditional methods to unlock their full potential for human health. Their innovative approach focuses on understanding genetic diseases and developing customized editing strategies.
Highlighted product
Core business
EmendoBio | Home | Unlocking the true potential of CRISPR
EmendoBio is boldly evolving traditional CRISPR solutions to make a positive impact on human health and previously incurable diseases.
Aldevron
Fargo, United States
B
101-250 Employees
1998
Key takeaway
Aldevron specializes in gene editing, offering custom-manufactured CRISPR-associated nucleases and Cas9 products designed for various applications like electroporation, transfection, and microinjection. Their expertise in high-quality plasmid DNA and proteins supports advanced therapeutic and vaccine development, making them a key player in the life sciences field.
Highlighted product
Product
CRISPR Cas9 Products | Aldevron
Aldevron offers gene editing Cas9 nucleases in defined formulations as well as custom-manufactured products to meet your specific needs. Our enzymes are engineered to be used in a variety of applications including electroporation, transfection and microinjection.
Technologies which have been searched by others and may be interesting for you:
The gene editing industry in the United States presents a dynamic landscape filled with various considerations. Regulatory frameworks play a crucial role, with organizations like the FDA and USDA overseeing the safety and efficacy of gene-edited products. It is essential to stay informed about evolving regulations, as they can significantly impact research, development, and commercialization efforts. Challenges such as ethical concerns and public perception also shape this industry, influencing funding and adoption rates. Opportunities abound, particularly in agriculture, medicine, and biotechnology, where gene editing techniques like CRISPR are being harnessed to enhance crop resilience and develop innovative therapies. The competitive landscape is marked by both established companies and startups, fostering a vibrant ecosystem of innovation and collaboration. Environmental concerns surrounding gene editing, especially in agriculture, warrant attention, as unintended consequences could arise from altered organisms. Furthermore, the global market relevance of gene editing is expanding, with international collaborations and research initiatives gaining momentum. Staying aware of these factors allows individuals and companies to navigate the complexities of the gene editing industry effectively while identifying potential pathways for growth and impact.
Some interesting numbers and facts about your company results for Gene Editing
Country with most fitting companies | United States |
Amount of fitting manufacturers | 2327 |
Amount of suitable service providers | 1767 |
Average amount of employees | 11-50 |
Oldest suiting company | 1998 |
Youngest suiting company | 2019 |
Some interesting questions that has been asked about the results you have just received for Gene Editing
What are related technologies to Gene Editing?
Based on our calculations related technologies to Gene Editing are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Gene Editing?
The most represented industries which are working in Gene Editing are Biotechnology, Other, IT, Software and Services, Healthcare, Medical
How does ensun find these Gene Editing Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.